12:00 AM
 | 
Aug 29, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

NovaDel, Rechon sales and marketing update

NovaDel granted Rechon an exclusive license to manufacture and commercialize ZolpiMist zolpidem oral spray outside the U.S. and Canada. Rechon is responsible for regulatory submissions in the EU...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >